Cheap Version Of Merck Covid Pill To Be Made For Poorer Nations

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERSA UN-backed agency has struck a deal with nearly 30 generic drugmakers to make low-cost versions of Merck's COVID-19 pill molnupiravir for poorer countries, expanding access to a drug seen as a weapon to fight the pandemic.

BING NEWS:
  • Moderna’s COVID vaccine sales plunge, as analysts debate future of once-hot company
    Sales of Spikevax, the Cambridge company’s only marketed product, plummeted to $167 million from $1.9 billion, the firm reported on Thursday. That actually beat analysts’ predictions of $97.5 million.
    05/2/2024 - 12:49 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News